A comprehensive map of the mTOR signaling network

被引:172
作者
Caron, Etienne [1 ,2 ]
Ghosh, Samik [3 ]
Matsuoka, Yukiko [3 ,4 ]
Ashton-Beaucage, Dariel [1 ]
Therrien, Marc [1 ,5 ]
Lemieux, Sebastien [1 ,9 ]
Perreault, Claude [1 ,2 ]
Roux, Philippe P. [1 ,5 ]
Kitano, Hiroaki [3 ,6 ,7 ,8 ]
机构
[1] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada
[2] Univ Montreal, Fac Med, Dept Med, Montreal, PQ H3C 3J7, Canada
[3] Syst Biol Inst, Minato Ku, Tokyo 1080071, Japan
[4] JST ERATO KAWAOKA Infect Induced Host Responses P, Tokyo, Japan
[5] Univ Montreal, Fac Med, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada
[6] Sony Comp Sci Labs, Shinagawa Ku, Tokyo, Japan
[7] Japanese Fdn Canc Res, Inst Canc, Div Syst Biol, Tokyo 170, Japan
[8] Okinawa Inst Sci & Technol, Open Biol Unit, Okinawa, Japan
[9] Univ Montreal, Fac Arts & Sci, Dept Comp Sci & Operat Res, Montreal, PQ H3C 3J7, Canada
基金
日本学术振兴会; 加拿大健康研究院;
关键词
cancer; CellDesigner; graphical notation; mTOR; regulatory network; RIBOSOMAL S6 KINASE; TUMOR-SUPPRESSOR COMPLEX; RICH AKT SUBSTRATE; 40 KDA PRAS40; MAMMALIAN TARGET; CELL-GROWTH; TUBEROUS SCLEROSIS; TSC1-TSC2; COMPLEX; CANCER-THERAPY; RAPAMYCIN MTOR;
D O I
10.1038/msb.2010.108
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mammalian target of rapamycin (mTOR) is a central regulator of cell growth and proliferation. mTOR signaling is frequently dysregulated in oncogenic cells, and thus an attractive target for anticancer therapy. Using CellDesigner, a modeling support software for graphical notation, we present herein a comprehensive map of the mTOR signaling network, which includes 964 species connected by 777 reactions. The map complies with both the systems biology markup language (SBML) and graphical notation (SBGN) for computational analysis and graphical representation, respectively. As captured in the mTOR map, we review and discuss our current understanding of the mTOR signaling network and highlight the impact of mTOR feedback and crosstalk regulations on drug-based cancer therapy. This map is available on the Payao platform, a Web 2.0 based community-wide interactive process for creating more accurate and information-rich databases. Thus, this comprehensive map of the mTOR network will serve as a tool to facilitate systems-level study of up-to-date mTOR network components and signaling events toward the discovery of novel regulatory processes and therapeutic strategies for cancer. Molecular Systems Biology 6: 453; published online 21 December 2010; doi:10.1038/msb.2010.108
引用
收藏
页数:14
相关论文
共 119 条
[21]   Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? [J].
Corradetti, M. N. ;
Guan, K-L .
ONCOGENE, 2006, 25 (48) :6347-6360
[22]   Bow ties, metabolism and disease [J].
Csete, M ;
Doyle, J .
TRENDS IN BIOTECHNOLOGY, 2004, 22 (09) :446-450
[23]   mTOR controls mitochondrial oxidative function through a YY1-PGC-1α transcriptional complex [J].
Cunningham, John T. ;
Rodgers, Joseph T. ;
Arlow, Daniel H. ;
Vazquez, Francisca ;
Mootha, Vamsi K. ;
Puigserver, Pere .
NATURE, 2007, 450 (7170) :736-U12
[24]   mToR signaling and drug development in cancer [J].
Dancey, Janet .
NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (04) :209-219
[25]   Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling [J].
DeYoung, Maurice Phillip ;
Horak, Peter ;
Sofer, Avi ;
Sgroi, Dennis ;
Ellisen, Leif W. .
GENES & DEVELOPMENT, 2008, 22 (02) :239-251
[26]   Characterization of Rictor Phosphorylation Sites Reveals Direct Regulation of mTOR Complex 2 by S6K1 [J].
Dibble, Christian C. ;
Asara, John M. ;
Manning, Brendan D. .
MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (21) :5657-5670
[27]   mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs [J].
Dowling, Ryan J. O. ;
Topisirovic, Ivan ;
Alain, Tommy ;
Bidinosti, Michael ;
Fonseca, Bruno D. ;
Petroulakis, Emmanuel ;
Wang, Xiaoshan ;
Larsson, Ola ;
Selvaraj, Anand ;
Liu, Yi ;
Kozma, Sara C. ;
Thomas, George ;
Sonenberg, Nahum .
SCIENCE, 2010, 328 (5982) :1172-1176
[28]   Dissecting the role of mTOR: Lessons from mTOR inhibitors [J].
Dowling, Ryan J. O. ;
Topisirovic, Ivan ;
Fonseca, Bruno D. ;
Sonenberg, Nahum .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2010, 1804 (03) :433-439
[29]   Current Status and Challenges Associated with Targeting mTOR for Cancer Therapy [J].
Dowling, Ryan J. O. ;
Pollak, Michael ;
Sonenberg, Nahum .
BIODRUGS, 2009, 23 (02) :77-91
[30]   Mammalian target of rapamycin complex 1: Signalling inputs, substrates and feedback mechanisms [J].
Dunlop, E. A. ;
Tee, A. R. .
CELLULAR SIGNALLING, 2009, 21 (06) :827-835